日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations

对于伴有KIT基因9号外显子突变的胃肠道间质瘤患者,辅助伊马替尼治疗或观察的疗效评价

Napolitano, Andrea; Joensuu, Heikki; Rothschild, Sara; Evans, Denisse; Heinrich, Michael C; Sutton, Thomas L; Mayo, Skye C; Boye, Kjetil; Falkenhorst, Johanna; Le Cesne, Axel; Hohenberger, Peter; Rutkowski, Piotr; van Houdt, Winan J; Steeghs, Neeltje; Gelderblom, Hans; Desar, Ingrid M E; Pantaleo, Maria A; Nishida, Toshiro; Reichardt, Peter; Blay, Jean-Yves; Somaiah, Neeta; Haddad, Elise F Nassif; Grignani, Giovanni; Baldi, Giacomo G; Steigen, Sonja E; Braconi, Chiara; Nilsson, Bengt; Singh, Arun S; Fumagalli, Elena; Cananzi, Ferdinando C M; Italiano, Antoine; Ceruso, Mariella Spalato; Brunello, Antonella; Magnússon, Magnús K; Jonasson, Jon G; Marquina, Gloria; Hindi, Nadia; Cirilli, Claudia; Federico, Massimo; Fausti, Valentina; Bordoni, Andrea; Sufliarsky, Jozef; Mazzocca, Alessandro; Martin-Broto, Javier; Gronchi, Alessandro; Trent, Jonathan C; Casali, Paolo G; Bauer, Sebastian; Jones, Robin L; Vincenzi, Bruno

Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors

一项针对晚期实体瘤患者的 cergutuzumab amunaleukin I 期研究的活性生物标志物

Melero, Ignacio; Steeghs, Neeltje; Lassen, Ulrik; Homicsko, Krisztian; Tabernero, Josep; Cañamero, Marta; Roller, Andreas; Duarte, José; Rossmann, Eva; Babitzki, Galina; Grabole, Nils; Watson, Carl; Habigt, Christin; Evers, Stefan; Dejardin, David; Teichgräber, Volker; Charo, Jehad

Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors

Cergutuzumab Amunaleukin 与 Atezolizumab 联合治疗癌胚抗原阳性晚期/转移性实体瘤患者

Melero, Ignacio; Tabernero, Josep; Steeghs, Neeltje; Robbrecht, Debbie G J; Peters, Solange; Rizvi, Naiyer A; O'Reilly, Eileen M; Calvo, Emiliano; Eefsen, Rikke L; Leighl, Natasha; Cervantes, Andres; Hafez, Navid; Habigt, Christin; Andersson, Emilia; Dejardin, David; Rossmann, Eva; Martinez Quetglas, Iris; Babitzki, Galina; Duarte, José; Adessi, Celine; Boetsch, Christophe; Evers, Stefan; Charo, Jehad; Teichgräber, Volker; Lassen, Ulrik

Evaluation of homologous recombination testing in ovarian carcinoma

卵巢癌同源重组检测的评价

Witjes, Vera M; de Hullu, Joanne A; van Remortele, Angela; Vreede, Lilian; Rosenberg, Efraim H; Cillessen, Saskia A G M; Groenendijk, Floris H; Steeghs, Elisabeth M P; Moonen, Laura; Mensenkamp, Arjen R; Ter Elst, Arja; de Leng, Wendy W J; Hoogerbrugge, Nicoline; Ligtenberg, Marjolijn J L

Quality of Life and Experiences of Patients with Gastrointestinal Stromal Tumors (GIST) on Imatinib Treatment

接受伊马替尼治疗的胃肠道间质瘤(GIST)患者的生活质量和体验

Westerdijk, Kim; Steeghs, Neeltje; van der Graaf, Winette T A; Groen, Joost S; van Erp, Nielka P; Hermens, Rosella P M G; Desar, Ingrid M E

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study

利用深度学习预测胃肠道间质瘤的突变和预后:一项多中心、多国研究

Bonetti, A; Le, V L; Carrero, Z I; Wolf, F; Gustav, M; Lam, S W; Vanhersecke, L; Sobczuk, P; Le Loarer, F; Lenarcik, M; Rutkowski, P; van Sabben, J M; Steeghs, N; van Boven, H; Machado, I; Bagué, S; Navarro, S; Medina-Ceballos, E; Agra, C; Giner, F; Tapia, G; Hernández-Gallego, A; Civantos Jubera, G; Cuatrecasas, M; Lopez-Prades, S; Perret, R E; Soubeyran, I; Khalifa, E; Blouin, L; Wardelmann, E; Meurgey, A; Collini, P; Voloshin, A; Yatabe, Y; Hirano, H; Gronchi, A; Nishida, T; Bouché, O; Emile, J F; Ngo, C; Hohenberger, P; Cotarelo, C; Jakob, J; Bovee, J V M G; Gelderblom, H; Szumera-Cieckiewicz, A; Jean-Denis, M; Bollard, J; Lassau, N; Lecesne, A; Blay, J Y; Italiano, A; Crombé, A; Coindre, J M; Kather, J N

Health-related quality of life in patients with advanced soft tissue sarcoma receiving first-line palliative chemotherapy (HOLISTIC): longitudinal results from a prospective, observational cohort study

接受一线姑息化疗的晚期软组织肉瘤患者的健康相关生活质量(HOLISTIC):一项前瞻性观察性队列研究的纵向结果

Roets, Evelyne; Younger, Eugenie; Jones, Robin L; Hollander, Dide den; Azarang, Leyla; Desar, Ingrid M E; Young, Robin J; Oosten, Astrid W; de Haan, Jacco J; Gelderblom, Hans; Steeghs, Neeltje; Husson, Olga; van der Graaf, Winette T A

Palbociclib exposure in relation to efficacy and toxicity in patients with advanced breast cancer

帕博西尼暴露量与晚期乳腺癌患者的疗效和毒性关系

Buijs, S M; Mohmaed Ali, M I; Oomen-de Hoop, E; Braal, C L; Wortelboer, N; van Ommen-Nijhof, A; Sonke, G S; Konings, I R; Jager, A; Steeghs, N; Siebinga, H; Mathijssen, R H J; Huitema, A D R; Koolen, S L W

Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy

tarlatamab治疗第1周期采用6-8小时门诊监测与48小时住院监测的安全性比较:DeLLphi-300 1期子研究

Chiang, A C; Olmedo Garcia, M E; Carlisle, J W; Dowlati, A; Reguart, N; Felip, E; Jost, P J; Steeghs, N; Stec, R; Gadgeel, S M; Loong, H H; Jiang, W; Hamidi, A; Parkes, A; Paz-Ares, L

The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma

全基因组测序在指导软组织肉瘤患者全身治疗中的作用

van der Laan, P; van Houdt, W J; van Boven, H; Snaebjornsson, P; Bosch, L J W; Monkhorst, K; Schrage, Y M; Heimans, L; Kerst, J M; Steeghs, N; van der Graaf, W T A